Manasi Jogalekar
Manasi Jogalekar
UCSF Helen Diller Family Comprehensive Cancer Center
Verified email at
Cited by
Cited by
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions
MP Jogalekar, A Veerabathini, P Gangadaran
Experimental Biology and Medicine 245 (11), 964-969, 2020
A mini-review on the effects of COVID-19 on younger individuals
M Manivannan, MP Jogalekar, MS Kavitha, BAV Maran, P Gangadaran
Experimental biology and medicine 246 (3), 293-297, 2021
SARS-CoV-2 variants: A double-edged sword?
MP Jogalekar, A Veerabathini, P Gangadaran
Experimental Biology and Medicine 246 (15), 1721-1726, 2021
Morphometric analysis of a triple negative breast cancer cell line in hydrogel and monolayer culture environments
MP Jogalekar, EE Serrano
PeerJ 6, e4340, 2018
Noninvasive in vivo cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment
RL Rajendran, MP Jogalekar, P Gangadaran, BC Ahn
World Journal of Stem Cells 12 (12), 1492, 2020
Urine biomarkers of kidney tubule health, injury, and inflammation are associated with progression of CKD in children
JH Greenberg, AG Abraham, Y Xu, JR Schelling, HI Feldman, ...
Journal of the American Society of Nephrology 32 (10), 2664-2677, 2021
Hydrogel environment supports cell culture expansion of a grade IV astrocytoma
MP Jogalekar, LG Cooper, EE Serrano
Neurochemical research 42 (9), 2610-2624, 2017
Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery
A Krishnan, P Gangadaran, VP Chavda, MP Jogalekar, R Muthusamy, ...
Experimental Biology and Medicine, 15353702221092984, 2022
Recent developments in autophagy-targeted therapies in cancer
MP Jogalekar, A Veerabathini, P Gangadaran
Experimental Biology and Medicine 246 (2), 207-212, 2021
Prebiotic Potential and Value-Added Products Derived from Spirulina laxissima SV001—A Step towards Healthy Living
V Sankarapandian, K Nitharsan, K Parangusadoss, P Gangadaran, ...
BioTech 11 (2), 13, 2022
An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer
V Sankarapandian, BA Venmathi Maran, RL Rajendran, MP Jogalekar, ...
Life 12 (1), 59, 2022
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development
MP Jogalekar, A Veerabathini, AB Patel
Experimental Biology and Medicine 246 (13), 1533-1540, 2021
Total RNA Isolation from Separately Established Monolayer and Hydrogel Cultures of Human Glioblastoma Cell Line
MP Jogalekar, EE Serrano
Bio-protocol 9 (14), e3305, 2019
COVID-19 and diabetes: What do we know so far?
P Gangadaran, H Padinjarathil, SHS Rajendran, MP Jogalekar, CM Hong, ...
Experimental Biology and Medicine, 15353702221108914, 2022
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
JG Amatruda, R Katz, MJ Sarnak, OM Gutierrez, JH Greenberg, ...
Kidney International Reports, 2022
Plasma Biomarkers as Risk Factors for Incident CKD
MJ Sarnak, R Katz, JH Ix, PL Kimmel, JV Bonventre, J Schelling, ...
Kidney International Reports, 2022
Application of Orthobiologics in Achilles Tendinopathy: A Review
LC Ramires, M Jeyaraman, S Muthu, N Shankar A, GS Santos, ...
Life 12 (3), 399, 2022
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
MP Jogalekar, RL Rajendran, F Khan, C Dmello, P Gangadaran, BC Ahn
Frontiers in Immunology 13, 2022
Post-Translational Tubulin Modifications in Differentiated Human Neural Stem Cells
VB Knight, MP Jogalekar, EE Serrano
bioRxiv, 2021.12. 31.474563, 2022
NP-ALT, a Liposomal: Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells
I Jilishitz, JL Quiñones, P Patel, G Chen, J Pasetsky, A VanInwegen, ...
Molecular Cancer Research 19 (11), 1929-1945, 2021
The system can't perform the operation now. Try again later.
Articles 1–20